Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.

Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.
复制标题

DOI:
10.1016/j.ccr.2009.05.009
复制
发表时间:
2009-07-07
期刊:
影响因子:
50.3
通讯作者:
Cichowski K
Cichowski K
中科院分区:
医学1区
文献类型:
--
作者:
McGillicuddy LT;Fromm JA;Hollstein PE;Kubek S;Beroukhim R;De Raedt T;Johnson BW;Williams SM;Nghiemphu P;Liau LM;Cloughesy TF;Mischel PS;Parret A;Seiler J;Moldenhauer G;Scheffzek K;Stemmer-Rachamimov AO;Sawyers CL;Brennan C;Messiaen L;Mellinghoff IK;Cichowski K

文献摘要

参考文献

被引文献

相似文献

NF1 肿瘤抑制因子的功能缺失突变导致 Ras 信号传导失调,并驱动 I 型家族性癌症综合征神经纤维瘤病的肿瘤发生。然而,NF1 失活在多大程度上促进散发性肿瘤发生尚不清楚。在这里,我们报告说,NF1 在散发性神经胶质瘤中通过两种机制失活:过度蛋白酶体降解和遗传丢失。 NF1 蛋白不稳定是由蛋白激酶 C (PKC) 过度激活引发的,并赋予对 PKC 抑制剂的敏感性。然而,仅当 p53 失活时才会发生完全的遗传丢失,从而介导对 mTOR 抑制剂的敏感性。这些研究揭示了 NF1 失活在散发性胶质瘤发生中的不断扩大的作用,并说明了如何在遗传上不同的肿瘤中利用不同的失活机制,从而影响治疗敏感性。肿瘤抑制因子在人类癌症中经常发生突变;然而,抑癌蛋白的过度蛋白酶体破坏也会促进肿瘤发生。在这里,我们发现由于 PKC 过度激活,NF1 蛋白在散发性 GBM 中不稳定。值得注意的是,这种不稳定导致对 PKC 抑制剂的敏感性。相比之下,具有 NF1 突变的 GBM 的一个单独子集对 PKC 抑制剂不敏感,但对 mTOR 抑制剂敏感。这些发现揭示了 NF1 失活在神经胶质瘤发生中的广泛作用,并说明了如何在同一肿瘤类型中利用不同的失活机制。此外,他们强调了阐明肿瘤发生的分子机制的重要性,因为这些知识对于开发个性化疗法可能至关重要。
Loss-of-function mutations in the NF1 tumor suppressor result in deregulated Ras signaling and drive tumorigenesis in the familial cancer syndrome neurofibromatosis type I. However, the extent to which NF1-inactivation promotes sporadic tumorigenesis is unknown. Here we report that NF1 is inactivated in sporadic gliomas via two mechanisms: excessive proteasomal degradation and genetic loss. NF1 protein destabilization is triggered by the hyperactivation of protein kinase C (PKC) and confers sensitivity to PKC inhibitors. However complete genetic loss, which only occurs when p53 is inactivated, mediates sensitivity to mTOR inhibitors. These studies reveal an expanding role for NF1-inactivation in sporadic gliomagenesis and illustrate how different mechanisms of inactivation are utilized in genetically distinct tumors, which consequently impacts therapeutic sensitivity. Tumor suppressors are often mutated in human cancer; however, the excessive proteasomal destruction of tumor suppressor proteins also promotes tumorigenesis. Here we show that the NF1 protein is destabilized in sporadic GBMs as a consequence of the hyperactivation of PKC. Notably, this destabilization confers sensitivity to PKC inhibitors. In contrast, a separate subset of GBMs that possess NF1 mutations are insensitive to PKC inhibitors but are sensitive to mTOR inhibitors. These findings reveal a broad role for NF1-inactivation in gliomagenesis and illustrate how different mechanisms of inactivation are utilized in the same tumor-type. Moreover they highlight the importance of elucidating the molecular mechanisms that underlie tumorigenesis, as such knowledge may be essential for developing personalized therapies.
DOI: 10.1016/0092-8674(92)90408-5
发表时间: 1992-04-17
期刊: CELL
影响因子: 64.5
作者:
LI, Y;BOLLAG, G;CAWTHON, R
通讯作者: CAWTHON, R
雷帕霉素在I期试验中针对复发性PTEN缺陷型胶质母细胞瘤患者的抗肿瘤活性。
DOI: 10.1371/journal.pmed.0050008
发表时间: 2008-01-22
期刊: PLOS MEDICINE
影响因子: 15.8
作者:
Cloughesy, Tim F.;Yoshimoto, Koji;Nghiemphu, Phioanh;Brown, Kevin;Dang, Julie;Zhu, Shaojun;Hsueh, Teli;Chen, Yinan;Wang, Wei;Youngkin, David;Liau, Linda;Martin, Neil;Becker, Don;Bergsneider, Marvin;Lai, Albert;Green, Richard;Oglesby, Tom;Koleto, Michael;Trent, Jeff;Horvath, Steve;Mischel, Paul S.;Mellinghoff, Ingo K.;Sawyers, Charles L.
通讯作者: Sawyers, Charles L.
DOI: 10.1073/pnas.92.20.9363
发表时间: 1995-09-26
影响因子: 11.1
作者:
DIMRI, GP;LEE, XH;CAMPISI, J
通讯作者: CAMPISI, J
DOI: 10.1126/science.280.5360.109
发表时间: 1998-04-03
期刊: SCIENCE
影响因子: 56.9
作者:
Marais, R;Light, Y;Marshall, CJ
通讯作者: Marshall, CJ
DOI: 10.1016/0092-8674(90)90253-b
发表时间: 1990-07-13
期刊: CELL
影响因子: 64.5
作者:
CAWTHON, RM;WEISS, R;WHITE, R
通讯作者: WHITE, R